# FDA Inspection 1111164 - Martin Neil Reaume, MD - November 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/martin-neil-reaume-md/0e001109-dfa6-4f31-89b3-850613fe8e08
Source feed: FDA_Inspections

> FDA Inspection 1111164 for Martin Neil Reaume, MD on November 15, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111164
- Company Name: Martin Neil Reaume, MD
- Inspection Date: 2019-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1278441 - 2025-07-25](https://www.keypedia.com/records/fda_inspections/martin-neil-reaume-md/422a6722-2f9e-40ce-84a4-c7b1c82243b6)
- [FDA Inspection 1278441 - 2025-07-25](https://www.keypedia.com/records/fda_inspections/martin-neil-reaume-md/89a6a364-4c92-4df7-badb-73770b832b68)

Company: https://www.keypedia.com/companies/martin-neil-reaume-md/6750f782-b99a-488c-9e9d-47fdef1e496b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c